Blood Transfusions

DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/08f4d0/epidemiology_hepa) has announced the addition of the "Epidemiology: Hepatitis C in China - Epidemic yet to reach its peak" report to their offering. In 1999, an estimated 180 million...

WASHINGTON -- If you're a high school or college student who is uncertain about your career choice and your future, maybe it's time for a big dose of career inspiration at the USA...

CONCORD, Calif. -- Cerus Corporation (NASDAQ:CERS) announced today that Andrew Gomperts has joined the company as chief business officer and vice president, business development and marketing. Mr. Gomperts will be responsible for establishing...

ATLANTA -- Georgia Bio announced its 2012 Deals of the Year for pharmaceutical, biopharmaceutical and medical device companies in four categories - public and private financings, fast growing companies, acquisitions and SBIR grants...

Blood banking is about people. Laboratorians who work in the blood bank rarely see the donors who supply the blood that they will prepare for transfusion. They rareiy meet the patients who receive...

A common challenge faced by many healthcare organizations is the lack of access and availability of transfusion medicine information to clinicians. Information on sample availability, antibodies, and transfusion reactions may not be easily...

The demand for providing safe, compatible blood at an ever-increasing pace is growing in hospitals and other healthcare facilities around the world. Every two seconds in the United States, someone, somewhere, needs a...

Strengths...

Strengths The only producer of vaccines and biological products in Egypt. In-house R&D capacities. No major competitors in the region. One of the main blood banks in the country. Weaknesses Sizeable counterfeit activity...

Although Revlimid currently is not approved for the treatment of non-deletion MDS it is used in this setting because of limited alternatives. The rationale for the combination of Telintra and Revlimid is based...

THALASSA investigated whether patients with NTDT and iron overload can benefit from iron chelation therapy as determined by liver iron concentration, or LIC. The study met its primary endpoint, showing that Exjade at...

Additional $5,000 for winner of online public voting SAN DIEGO -- Programs that teach coping skills to homeless children, adult life skills to foster and runaway youth, and emergency preparedness to kids are...

BOULDER, Colo. -- Array BioPharma Inc. (NASDAQ: ARRY) today announced positive dose-escalation/expansion data for its novel, small molecule dual p38/Tie2 inhibitor, ARRY-614. The data were presented at the 2011 Annual Meeting of the...

Incyte to host a webcast for investors featuring these results on Monday, December 12 at 7:00 p.m. PT SAN DIEGO -- Incyte Corporation (Nasdaq:INCY) today announced that further analyses from the global, pivotal...

Results Indicate Bone Marrow Reduces Risk of Graft-Versus-Host Disease Compared to Peripheral Blood Stem Cells SAN DIEGO -- Patients who receive a blood stem cell transplant from a donor outside of their family...

- Oral Rigosertib (ON 01910.Na) Advancing to Phase II - - Rigosertib-Mediated Inhibition of PI3K & MAPK Pathways Validated in Patient Bone Marrow Samples - NEWTOWN, Pa. & PENNINGTON, N.J. -- Onconova Therapeutics...

Experts to review newly published study showing value of day-of-transfusion testing LAKE ZURICH, Ill. -- Fenwal Inc. announced today it is hosting a live, online educational lecture on January 12, 2012, at 1:00...

CONCORD, Calif. -- Cerus Corporation (NASDAQ:CERS) announced today that William "Obi" Greenman, president and chief executive officer, is scheduled to present a corporate update at the Oppenheimer 22nd Annual Healthcare Conference in New...

CONCORD, Calif. -- Cerus Corporation (NASDAQ: CERS) announced today that Russia's Federal Medical-Biological Agency (FMBA) has awarded contracts for the purchase of 19 INTERCEPT Blood System illumination devices for blood centers throughout the...